{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Pao Pereira", "Rauwolfia vomitoria", "cancer stem cells", "medicinal plant", "natural product", "ovarian cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36178054", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["15347354221123019", "10.1177/15347354221123019"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "21", "PubDate": {"Year": "2022", "Season": "Jan-Dec"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Extracts of the Medicinal Plants <i>Pao Pereira</i> and <i>Rauwolfia vomitoria</i> Inhibit Ovarian Cancer Stem Cells <i>In Vitro</i>.", "Pagination": {"StartPage": "15347354221123019", "MedlinePgn": "15347354221123019"}, "Abstract": {"AbstractText": ["Ovarian cancer has an enrichment of cancer stem cells (CSCs) which contribute to the treatment resistant tumor's high rate of recurrence and metastasis. Here we investigated 2 plant extracts from the medicinal plants Pao Pereira (Pao) and <i>Rauwolfia vomitoria</i> (Rau) each for their activities against ovarian CSCs. Both Pao and Rau inhibited overall proliferation of human ovarian cancer cell lines with IC<sub>50</sub> ranging from 210 to 420\u2009\u03bcg/mL and had limited cytotoxicity to normal epithelial cells. Ovarian CSC population was examined using cell surface markers and tumor spheroid formation assays. The results showed that both Pao and Rau treatment significantly reduced the ovarian CSC population. Pao and Rau had similar activities in inhibiting ovarian CSCs, with IC<sub>50</sub>s of ~120\u2009\u03bcg/mL for 24\u2009hours treatment, and ~50\u2009\u03bcg/mL for long-term tumor spheroid formation. Nuclear \u03b2-catenin levels were decreased, suggesting suppression of Wnt/\u03b2-catenin signaling pathway. Taken together, data here showed that Pao and Rau both inhibited ovarian cancer stem cells, probably in preference to the bulk of tumor cells. Further mechanistic studies and <i>in vivo</i> investigation validating these findings are warranted, given that inhibition of cancer stem cells holds the promise of comprehensively inhibiting cancer metastasis, drug resistance and recurrence."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Chen", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Dong", "ForeName": "Ruochen", "Initials": "R"}, {"Identifier": ["0000-0002-7173-8411"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Kansas Medical Center, Kansas City, KS, USA."}], "LastName": "Chen", "ForeName": "Qi", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "beta Catenin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rauwolfia"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta Catenin"}], "CoiStatement": "<b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\nAmerican Cancer Society. Cancer facts and figures 2022. American Cancer Society. 2022. Accessed February 18, 2022. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html"}, {"Citation": "Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.", "ArticleIdList": ["PMC7290868", "27558151"]}, {"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.", "ArticleIdList": ["28055103"]}, {"Citation": "McGuire WP, Hoskins WJ, Brady MF, et al.. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. New Engl J Med. 1996;334:1-6.", "ArticleIdList": ["7494563"]}, {"Citation": "Vergote I, Trop\u00e9 CG, Amant F, et al.. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. New Engl J Med. 2010;363:943-953.", "ArticleIdList": ["20818904"]}, {"Citation": "Patch AM, Christie EL, Etemadmoghadam D, et al.. Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015;521:489-494.", "ArticleIdList": ["26017449"]}, {"Citation": "Burger RA, Brady MF, Bookman MA, et al.. Incorporation of bevacizumab in the primary treatment of ovarian cancer. New Engl J Med. 2011;365:2473-2483.", "ArticleIdList": ["22204724"]}, {"Citation": "Oza AM, Cook AD, Pfisterer J, et al.. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015;16:928-936.", "ArticleIdList": ["PMC4648090", "26115797"]}, {"Citation": "Gelmon KA, Tischkowitz M, Mackay H, et al.. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. Lancet Oncol. 2011;12:852-861.", "ArticleIdList": ["21862407"]}, {"Citation": "Kaufman B, Shapira-Frommer R, Schmutzler RK, et al.. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol. 2015;33:244-250.", "ArticleIdList": ["PMC6057749", "25366685"]}, {"Citation": "Ledermann J, Harter P, Gourley C, et al.. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. New Engl J Med. 2012;366:1382-1392.", "ArticleIdList": ["22452356"]}, {"Citation": "Duong M, Wright E, Yin L, Martin-Nunez I, Ghatage P, Fung-Kee-Fung M. The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada. Curr Oncol. 2016;23:e461-e467.", "ArticleIdList": ["PMC5081018", "27803606"]}, {"Citation": "Semenza GL. A new weapon for attacking tumor blood vessels. New Engl J Med. 2008;358:2066-2067.", "ArticleIdList": ["18463385"]}, {"Citation": "Zeimet AG, Reimer D, Sopper S, et al.. Ovarian cancer stem cells. Neoplasma. 2012;59:747-755.", "ArticleIdList": ["22862176"]}, {"Citation": "Burgos-Ojeda D, Rueda BR, Buckanovich RJ. Ovarian cancer stem cell markers: Prognostic and Therapeutic Implications. Cancer Lett. 2012;322:1-7.", "ArticleIdList": ["PMC4431611", "22334034"]}, {"Citation": "Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer. 2013;13:727-738.", "ArticleIdList": ["24060864"]}, {"Citation": "Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.", "ArticleIdList": ["11689955"]}, {"Citation": "Ajani JA, Song S, Hochster HS, Steinberg IB. Cancer stem cells: the promise and the potential. Semin Oncol. 2015;42:S3-17.", "ArticleIdList": ["25839664"]}, {"Citation": "Vinogradov S, Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomed. 2012;7:597-615.", "ArticleIdList": ["PMC3376090", "22471722"]}, {"Citation": "Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Cancer stem cells and their role in metastasis. Pharmacol Ther. 2013;138:285-293.", "ArticleIdList": ["PMC3602306", "23384596"]}, {"Citation": "Yu Y, Ramena G, Elble RC. The role of cancer stem cells in relapse of solid tumors. Front Biosci. 2012;4:1528-1541.", "ArticleIdList": ["22201973"]}, {"Citation": "La Barre J. Hypotensive effects of the completely dereserpinised extract of Rauwolfia vomitoria. Arzneimittelforsch. 1973;23:600-605.", "ArticleIdList": ["4145743"]}, {"Citation": "Gbolade A. Ethnobotanical study of plants used in treating hypertension in Edo State of Nigeria. J Ethnopharmacol. 2012;144:1-10.", "ArticleIdList": ["22975417"]}, {"Citation": "Pesewu GA, Cutler RR, Humber DP. Antibacterial activity of plants used in traditional medicines of Ghana with particular reference to MRSA. J Ethnopharmacol. 2008;116:102-111.", "ArticleIdList": ["18096337"]}, {"Citation": "Kweifio-Okai G. Antiinflammatory activity of a Ghanaian antiarthritic herbal preparation: I. J Ethnopharmacol. 1991;33:263-267.", "ArticleIdList": ["1921424"]}, {"Citation": "La Barre J, Castiau J. [Effect of reserpine-free Rauwolfia vomitoria extract on gastric motility in dogs]. C R Seances Soc Biol Fil. 1957;151:2222-2224.", "ArticleIdList": ["13585757"]}, {"Citation": "Isaiah AM, Olawale O, Effiong EE, Idongesit NJ, Fidelis UA, Friday UU. Vitamin e supplementation with rauwolfia vomitoria root bark extract improves hematological indices. N Am J Med Sci. 2012;4:86-89.", "ArticleIdList": ["PMC3296325", "22408754"]}, {"Citation": "Bemis DL, Capodice JL, Gorroochurn P, Katz AE, Buttyan R. Anti-prostate cancer activity of a beta-carboline alkaloid enriched extract from Rauwolfia vomitoria. Int J Oncol. 2006;29:1065-1073.", "ArticleIdList": ["17016636"]}, {"Citation": "Bemis DL, Capodice JL, Desai M, Katz AE, Buttyan R. Beta-carboline alkaloid-enriched extract from the Amazonian rain forest tree Pao Pereira suppresses prostate cancer cells. J Soc Integr Oncol. 2009;7:59-65.", "ArticleIdList": ["PMC6358020", "19476740"]}, {"Citation": "Iwu MM, Court WE. Root alkaloids of Rauwolfia vomitoria afz. Planta Med. 1977;32:88-99.", "ArticleIdList": ["905421"]}, {"Citation": "Beljanski M, Beljanski MS. Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs. Oncology. 1986;43:198-203.", "ArticleIdList": ["3703465"]}, {"Citation": "Chen Q, Chao R, Chen H, et al.. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer. 2005;114:675-682.", "ArticleIdList": ["15609303"]}, {"Citation": "Yu J, Chen Q. The plant extract of Pao Pereira potentiates carboplatin effects against ovarian cancer. Pharm Biol. 2014;52:36-43.", "ArticleIdList": ["24033267"]}, {"Citation": "Yu J, Ma Y, Drisko J, Chen Q. Antitumor activities of Rauwolfia vomitoria extract and potentiation of carboplatin effects against ovarian cancer. Curr Ther Res Clin Exp. 2013;75:8-14.", "ArticleIdList": ["PMC3898180", "24465036"]}, {"Citation": "Dong R, Chen P, Chen Q. Extract of the medicinal plant Pao Pereira inhibits pancreatic cancer stem-like cell in vitro and in vivo. Integr Cancer Ther. 2018;17:1204-1215.", "ArticleIdList": ["PMC6247539", "29985062"]}, {"Citation": "Dong R, Chen P, Chen Q. Inhibition of pancreatic cancer stem cells by Rauwolfia vomitoria extract. Oncol Rep. 2018;40:3144-3154.", "ArticleIdList": ["PMC6196640", "30272287"]}, {"Citation": "Yu J, Drisko J, Chen Q. Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. Oncol Rep. 2013;30:149-156.", "ArticleIdList": ["23674070"]}, {"Citation": "Walters Haygood CL, Arend RC, Straughn JM, Buchsbaum DJ. Ovarian cancer stem cells: can targeted therapy lead to improved progression-free survival? World J Stem Cells. 2014;6:441-447.", "ArticleIdList": ["PMC4172672", "25258665"]}, {"Citation": "Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97-106.", "ArticleIdList": ["21151206"]}, {"Citation": "MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9-26.", "ArticleIdList": ["PMC2861485", "19619488"]}, {"Citation": "Amini S, Fathi F, Mobalegi J, Sofimajidpour H, Ghadimi T. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, bmi, zfx, tcl1, Tbx3, dppa4, and esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. Anat Cell Biol. 2014;47:1-11.", "ArticleIdList": ["PMC3968261", "24693477"]}, {"Citation": "Oettle H, Neuhaus P. Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs. 2007;67:2293-2310.", "ArticleIdList": ["17983252"]}, {"Citation": "Renouf D, Moore M. Evolution of systemic therapy for advanced pancreatic cancer. Expert Rev Anticancer Ther. 2010;10:529-540.", "ArticleIdList": ["20397918"]}, {"Citation": "Takebe N, Miele L, Harris PJ, et al.. Targeting Notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445-464.", "ArticleIdList": ["PMC4520755", "25850553"]}, {"Citation": "Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150-158.", "ArticleIdList": ["17306971"]}, {"Citation": "Yan R, Fan X, Xiao Z, et al.. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/\u03b2-catenin activity and cancer stemness. Cancer Lett. 2022;531:83-97.", "ArticleIdList": ["35157971"]}, {"Citation": "Jim\u00e9nez-Guerrero R, Belmonte-Fern\u00e1ndez A, Flores ML, et al.. Wnt/\u03b2-Catenin signaling contributes to paclitaxel resistance in bladder cancer cells with cancer stem cell-like properties. Int J Mol Sci. 2021;23:450.", "ArticleIdList": ["PMC8745426", "35008872"]}, {"Citation": "Mao J, Fan S, Ma W, et al.. Roles of Wnt/\u03b2-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:e1039.", "ArticleIdList": ["PMC4040703", "24481453"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "30", "Hour": "6", "Minute": "33"}, {"Year": "2022", "Month": "10", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36178054", "PMC9528043", "10.1177/15347354221123019"]}}], "PubmedBookArticle": []}